1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The esomeprazole magnesium enteric-coated tablets market is evolving rapidly as healthcare systems adapt to new patient demands and regulatory shifts. Effective formulations that enhance treatment adherence and integrate seamlessly with care pathways are gaining attention among key stakeholders in this sector.
Market Snapshot: Esomeprazole Magnesium Enteric-Coated Tablets
Industry growth for esomeprazole magnesium enteric-coated tablets is fueled by demographic shifts, emerging disease prevalence, and competitive product development. The segment serves as a fundamental therapy in managing acid-related disorders, with delivery technologies designed to optimize therapeutic outcomes and improve patient compliance. Strong demand is observed across healthcare systems adapting to shifting standards of care and increasing generic activity.
Scope & Segmentation
- Application Areas: Gastroesophageal reflux disease, peptic ulcer disease, and Zollinger-Ellison syndrome.
- Reflux Profiles: Erosive and non-erosive types influencing clinical monitoring and dose adjustments.
- Ulcer Subtypes: Duodenal and gastric ulcers, each necessitating tailored regimens.
- Distribution Channels: Hospital pharmacies (private/public), online platforms (e-commerce, telepharmacy), retail outlets (chain, independent).
- Administration Routes: Intravenous and oral modalities, supporting both acute and chronic care.
- Dosage Strengths: 10 mg, 20 mg, and 40 mg variants for flexible intervention.
- Dosage Forms: Tablet and capsule options determined by patient preference, packaging, and manufacturing dynamics.
- Regions Covered: Americas (notably US states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, and others), and Asia-Pacific (China, India, Japan, Southeast Asia, Australia, among others).
- Key Companies: Teva Pharmaceutical Industries, Viatris, AstraZeneca, Dr. Reddy’s, Sun Pharma, Sandoz, Lupin, Cipla, Torrent, and Zydus Lifesciences.
- Technologies Used: Multiparticulate beads, pH-sensitive polymers, digital therapeutics integration, remote monitoring tools, and advanced analytics for manufacturing.
Key Takeaways
- Innovation in esomeprazole magnesium tablet delivery is accelerating, focusing on patient-centric design and connected health solutions.
- Heightened regulatory scrutiny is driving elevated manufacturing standards, with emphasis on excipient sourcing and quality controls.
- Supply chain resilience is a top strategic priority, featuring dual-source procurement and greater inventory management sophistication.
- Regional variations shape product uptake, with Americas prioritizing support programs and Asia-Pacific leveraging digital distribution to reach expanding patient populations.
- Competitive strategies center on portfolio diversification, lifecycle management, and partnerships to enhance production scalability and value-added services.
- Cross-sector collaboration is fostering a more interconnected healthcare landscape, improving speed to market and care integration.
Tariff Impact: US Market Shifts in 2025
Tariff adjustments are transforming manufacturing footprints by increasing the costs of pharmaceutical inputs. In response, manufacturers are relocating synthesis operations to alternative jurisdictions and adopting dual-sourcing strategies to maintain production flows. Strategic supplier agreements, inventory management, and collaborative forecasting are deployed to stabilize margins and safeguard supply continuity.
Methodology & Data Sources
Primary research leveraged interviews with KOLs, formulary leads, and senior industry executives. Findings were cross-referenced with secondary sources—including peer-reviewed publications, regulatory documents, and proprietary databases. Multi-layered quality assurance and analytical validation underpin the reliability and relevance of the report.
Why This Report Matters
- Equips decision-makers with actionable insights to guide investment, product development, and supply chain strategy in the esomeprazole magnesium tablets space.
- Enables stakeholders to understand regulatory, technological, and competitive changes shaping opportunities across high-growth regions and distribution channels.
- Supports informed resource allocation by outlining actionable segmentation and channel optimization pathways.
Conclusion
The findings highlight essential levers for growth and risk mitigation in the esomeprazole magnesium enteric-coated tablets market. Adapting to technology trends, regional dynamics, and evolving stakeholder models will be crucial for maintaining long-term advantage.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of precision dosing strategies based on CYP2C19 genetic profiling to optimize esomeprazole magnesium therapy
5.2. Development of long-acting enteric-coated tablet formulations enabling once-weekly esomeprazole dosing schedules
5.3. Integration of digital adherence monitoring platforms and smart packaging for esomeprazole therapy management
5.4. Surge in demand for pediatric esomeprazole magnesium granules with flavor-masked, age-appropriate formulations
5.5. Entry of biosimilar esomeprazole magnesium tablets intensifying price competition and formulary negotiations
5.6. Advancements in nanoparticle-based enteric coating technologies enhancing targeted delivery of esomeprazole
5.7. Novel co-formulations combining esomeprazole magnesium with prokinetic agents for enhanced GERD management
5.8. Regulatory updates on bioequivalence requirements for enteric-coated proton pump inhibitors altering market entry timelines
5.2. Development of long-acting enteric-coated tablet formulations enabling once-weekly esomeprazole dosing schedules
5.3. Integration of digital adherence monitoring platforms and smart packaging for esomeprazole therapy management
5.4. Surge in demand for pediatric esomeprazole magnesium granules with flavor-masked, age-appropriate formulations
5.5. Entry of biosimilar esomeprazole magnesium tablets intensifying price competition and formulary negotiations
5.6. Advancements in nanoparticle-based enteric coating technologies enhancing targeted delivery of esomeprazole
5.7. Novel co-formulations combining esomeprazole magnesium with prokinetic agents for enhanced GERD management
5.8. Regulatory updates on bioequivalence requirements for enteric-coated proton pump inhibitors altering market entry timelines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Esomeprazole Magnesium Enteric-coated Tablets Market, by Application
8.1. Introduction
8.2. Gastroesophageal Reflux Disease
8.2.1. Erosive
8.2.2. Non Erosive
8.3. Peptic Ulcer Disease
8.3.1. Duodenal Ulcer
8.3.2. Gastric Ulcer
8.4. Zollinger Ellison Syndrome
8.2. Gastroesophageal Reflux Disease
8.2.1. Erosive
8.2.2. Non Erosive
8.3. Peptic Ulcer Disease
8.3.1. Duodenal Ulcer
8.3.2. Gastric Ulcer
8.4. Zollinger Ellison Syndrome
9. Esomeprazole Magnesium Enteric-coated Tablets Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.2.1. Private Hospital
9.2.2. Public Hospital
9.3. Online Pharmacy
9.3.1. E Commerce Platforms
9.3.2. Telepharmacy
9.4. Retail Pharmacy
9.4.1. Chain Pharmacy
9.4.2. Independent Pharmacy
9.2. Hospital Pharmacy
9.2.1. Private Hospital
9.2.2. Public Hospital
9.3. Online Pharmacy
9.3.1. E Commerce Platforms
9.3.2. Telepharmacy
9.4. Retail Pharmacy
9.4.1. Chain Pharmacy
9.4.2. Independent Pharmacy
10. Esomeprazole Magnesium Enteric-coated Tablets Market, by Route Of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
10.2. Intravenous
10.3. Oral
11. Esomeprazole Magnesium Enteric-coated Tablets Market, by Dosage Strength
11.1. Introduction
11.2. 10 Mg
11.3. 20 Mg
11.4. 40 Mg
11.2. 10 Mg
11.3. 20 Mg
11.4. 40 Mg
12. Esomeprazole Magnesium Enteric-coated Tablets Market, by Dosage Form
12.1. Introduction
12.2. Capsule
12.3. Tablet
12.2. Capsule
12.3. Tablet
13. Americas Esomeprazole Magnesium Enteric-coated Tablets Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Esomeprazole Magnesium Enteric-coated Tablets Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Esomeprazole Magnesium Enteric-coated Tablets Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Viatris Inc.
16.3.3. AstraZeneca PLC
16.3.4. Dr. Reddy’s Laboratories Ltd.
16.3.5. Sun Pharmaceutical Industries Ltd.
16.3.6. Sandoz International GmbH
16.3.7. Lupin Limited
16.3.8. Cipla Limited
16.3.9. Torrent Pharmaceuticals Ltd.
16.3.10. Zydus Lifesciences Ltd.
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Viatris Inc.
16.3.3. AstraZeneca PLC
16.3.4. Dr. Reddy’s Laboratories Ltd.
16.3.5. Sun Pharmaceutical Industries Ltd.
16.3.6. Sandoz International GmbH
16.3.7. Lupin Limited
16.3.8. Cipla Limited
16.3.9. Torrent Pharmaceuticals Ltd.
16.3.10. Zydus Lifesciences Ltd.
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET: RESEARCHAI
FIGURE 26. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 27. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET: RESEARCHCONTACTS
FIGURE 28. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET: RESEARCHAI
FIGURE 26. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET: RESEARCHSTATISTICS
FIGURE 27. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET: RESEARCHCONTACTS
FIGURE 28. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY EROSIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY EROSIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY NON EROSIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY NON EROSIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DUODENAL ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DUODENAL ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTRIC ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTRIC ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ZOLLINGER ELLISON SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ZOLLINGER ELLISON SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY TELEPHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY TELEPHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 10 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 10 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 20 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 20 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 40 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 40 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 122. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 123. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 124. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 125. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 130. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 131. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 132. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 133. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 136. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 137. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 138. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 148. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 149. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 150. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 151. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 241. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 250. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 251. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 252. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 253. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 258. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE,
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY EROSIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY EROSIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY NON EROSIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY NON EROSIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DUODENAL ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DUODENAL ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTRIC ULCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTRIC ULCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ZOLLINGER ELLISON SYNDROME, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ZOLLINGER ELLISON SYNDROME, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY TELEPHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY TELEPHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 10 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 10 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 20 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 20 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 40 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY 40 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 122. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 123. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 124. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 125. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 130. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 131. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 132. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 133. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 136. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 137. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 138. CANADA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 139. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 143. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 148. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 149. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 150. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 151. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 241. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2018-2024 (USD MILLION)
TABLE 244. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, 2025-2030 (USD MILLION)
TABLE 245. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY PEPTIC ULCER DISEASE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 250. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 251. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 252. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 253. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 254. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 255. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 258. GERMANY ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED TABLETS MARKET SIZE,
Samples
LOADING...
Companies Mentioned
The companies profiled in this Esomeprazole Magnesium Enteric-coated Tablets market report include:- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- AstraZeneca PLC
- Dr. Reddy’s Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- Sandoz International GmbH
- Lupin Limited
- Cipla Limited
- Torrent Pharmaceuticals Ltd.
- Zydus Lifesciences Ltd.
